Overview
Epidermal growth factor (EGF) is a 53-amino-acid polypeptide that binds the epidermal growth factor receptor (EGFR/ErbB1), a receptor tyrosine kinase whose activation triggers downstream RAS-MAPK and PI3K-AKT signaling to drive cell proliferation, survival, migration, and differentiation. The EGF/EGFR axis is central to epithelial tissue maintenance, wound healing, and angiogenesis, and its dysregulation contributes to oncogenesis, making EGFR a major target for tyrosine-kinase inhibitors and monoclonal antibodies in cancer therapy. Research associated with this topic reflects both the regenerative and oncological dimensions of growth-factor biology. Studies address wound healing and tissue repair, including the influence of acute versus chronic wound fluid in three-dimensional in-vitro models and amniotic membrane treatment of severe epidermal injury, alongside tissue-engineering approaches using stem cells. Oncology-focused work examines EGFR-directed therapeutics such as erlotinib and lapatinib, proteomic responses to targeted agents, biomarker discovery in carcinomas and sarcomas, and signaling pathways governing metastasis and epithelial-mesenchymal transition. Collectively, this peer-reviewed literature illustrates how EGF-related signaling informs regenerative medicine, molecular oncology, and the development and evaluation of receptor-targeted treatments across human and comparative models.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Acute and Chronic Wound Fluid Inversely Influence Wound Healing in an in-Vitro 3D Wound Model
Erlotinib Associated Trichomegaly in a Patient with Chronic Latanoprost Use
Robust Sampling of Defective Pathways in Parkinson Disease
Evaluation of Anti-Aging Activity of the Biofield Energy Treated Novel Test Formulation Using SIRT1 and Telomerase Activity in in Vitro Model
Medullary Thyroid Cancer: Is the Adequacy of Pre-Operative Evaluation Influenced by Training Background?
Laryngeal Tissue Engineering using Rabbit Adipose Derived Stem Cells in Fibrin: A Pre-Clinical Model
Overexpression of Prostate Apoptosis Response Protein-4 In Colon Cancer Cells Can Inhibit Metastasis by Upregulating E-cadherin Expression
Identification of Novel Biomarker for Human Uterine Leiomyosarcoma
Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy
Correlation of Oncotype DX Recurrence Score with the Expression of Insulin Receptor Substrate Proteins in Estrogen Receptor + Breast Cancer
Canine Periosteal Osteosarcoma
How this research is being cited
The 12 articles above have been cited 48 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BMC Bioinformatics
-
Rima Nuwayhid et al. · 2025 · Frontiers in Bioengineering and Biotechnology
-
2025 · Frontiers in Bioengineering and Biotechnology
-
2025 · The Laryngoscope
-
J. R. Muñoz-Torres et al. · 2023 · Frontiers in Bioengineering and Biotechnology
-
2023 · Journal of Breast Cancer
-
2023 · Frontiers in Bioengineering and Biotechnology
-
H. Vyas et al. · 2022 · Biofilm
A sample of recent works citing this journal's research on Epidermal Growth Factor, linking to each citing work.